# DESCRIPTION

## FIELD OF THE INVENTION

- relate to substances for insulin secretion stimulation

## BACKGROUND OF THE INVENTION

- describe insulin secretion mechanism
- explain incretin effect
- discuss diabetes mellitus types
- describe current treatments for diabetes
- highlight need for new treatments

## SUMMARY OF THE INVENTION

- describe Nogo-A knockout mice experiment
- summarize increased insulin secretion effect
- outline aspects of the invention

## DETAILED DESCRIPTION

- define insulin secretion deficiency
- define Nogo-A and its isoforms
- describe Nogo-A antagonists
- define Nogo-A antibody
- describe monoclonal antibody
- define humanised antibody
- describe donor antibody
- describe acceptor antibody
- define CDRs
- describe anti-Nogo-A antibody
- describe siRNA
- describe peptidomimetic
- describe production of Nogo-A protein
- define pharmaceutically acceptable
- define carrier
- define treatment and efficacy

### Nogo-A Antagonists

- describe Nogo-A antagonists
- describe specific Nogo-A antagonists

### Compositions

- introduce Nogo-A antagonists
- describe pharmaceutical compositions
- list pharmaceutically acceptable additional ingredients
- outline pharmaceutical formulation options
- discuss injectable compositions

### Mode of Administration

- describe administration methods

### Combination

- introduce combination therapy
- list co-agents for insulin secretion stimulation
- describe administration options for combination therapy

### Patients

- identify patient groups for treatment

## USE ACCORDING TO THE INVENTION

- provide uses of Nogo-A antagonist
- provide methods for controlling blood glucose levels
- provide uses of Nogo-A polypeptide or fragment
- specify embodiments of subjects and Nogo-A antagonists

## EXAMPLES

- introduce examples of Nogo-A expression and insulin secretion

### Example 1

- investigate Nogo-A expression in pancreas and islets
- describe Nogo-A knock-out mice generation and genotyping

### Example 2

- study insulin secretion profile in Nogo-A knock-out mice
- measure blood glucose and insulin release
- perform in vivo stimulation of β-cell secretion
- assess insulin content per β-cell
- investigate parasympathetic input and β-cell sensitivity
- measure plasma pancreatic polypeptide levels
- assess gluco-incretin input
- perform in vivo insulin secretion assays
- measure insulin tolerance tests
- perform vagally stimulated islet hormone secretion

### Example 3

- investigate in vitro sensitivity of β-cells to insulin secretagogues
- perform in vitro insulin secretion assays

### Example 4

- introduce Nogo-A antagonist treatment in diabetic animals
- describe experimental design and methods
- present results of insulin secretion and glucose levels
- analyze pancreatic insulin content and parasympathetic tone
- conclude benefits of Nogo-A neutralization for anti-diabetic treatment

### Statistical Analysis.

- describe statistical methods and software used

